Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $15.89 USD
Change Today -0.10 / -0.63%
Volume 44.8K
As of 8:10 PM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by ASTELLAS PHARMA INC-UNSP ADR (ALPMY) in the last 6 months

Announced 02/2/15
28.21B for Astellas Pharma, Inc.
Buyback

Astellas Pharma Inc. (TSE:4503) announces a share repurchase program. Under the program, the company will repurchase up to 15,000,000 shares, representing 0.68% of its outstanding share capital, for a total cost of ¥30,000 million. The purpose of the plan is to improve capital efficiency and shareholder return. The repurchases will be made until March 17, 2015. As of December 31, 2014, the company has 2,208,059,034 shares outstanding and 51,764,141 shares in treasury. The ...
Read More


ALPMY's price was unchanged after the transaction was announced on 02/2/15.
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALPMY:US $15.89 USD -0.10

ALPMY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Baxter International Inc $69.91 USD -0.24
Becton Dickinson and Co $141.53 USD -0.86
Boston Scientific Corp $18.40 USD +0.24
CSL Ltd A$94.06 AUD -0.77
Mylan NV $69.82 USD +2.98
View Industry Companies
 

Industry Analysis

ALPMY

Industry Average

Valuation ALPMY Industry Range
Price/Earnings 34.1x
Price/Sales 3.5x
Price/Book 3.1x
Price/Cash Flow 22.9x
TEV/Sales 3.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ASTELLAS PHARMA INC-UNSP ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.